Tasso Partners, LLC 3
3 · PAVmed Inc. · Filed Apr 6, 2026
Insider Transaction Report
Form 3
PAVmed Inc.PAVM
Tasso Partners, LLC
10% Owner
Holdings
- 912,996
Common Stock
Warrants
[F1]Exercise: $1000.00From: 2026-02-03Exp: 2031-02-03→ Series D Preferred Stock (5,365 underlying)
Footnotes (1)
- [F1]The Warrant entitles the reporting person to purchase up to 5,365 shares of Series D Preferred Stock at an exercise price of $1,000 per share. Each share of Series D Preferred Stock has a stated value of $1,000 per share and is convertible into shares of Common Stock at a conversion price of $6.50 per share, for an aggregate of up to 825,385 shares of Common Stock. Upon exercise of the Warrant, the Issuer may, in lieu of issuing the Series D Preferred Stock, issue to the reporting person the number of shares of Common Stock that would be issuable to the holder upon conversion of the Series D Preferred Stock.
Signature
/s/ Dana Carrera, as manager of managing member|2026-04-06